BioCorRx (BICX) Shares Outstanding (Diluted Average) (2011 - 2026)

BioCorRx has disclosed Shares Outstanding (Diluted Average) across 11 years of filings, most recently posting $25.6 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $25.6 million, up 69.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.6 million (up 69.59% YoY), and the FY2025 annual result was $18.5 million, up 76.66% from the prior year.
• Shares Outstanding (Diluted Average) came in at $25.6 million for Q1 2026 at BioCorRx, up from $18.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $25.6 million in Q1 2026 to a low of $9.7 million in Q3 2024.
• The 3-year median for Shares Outstanding (Diluted Average) is $16.0 million (2025), against an average of $16.0 million.
• Across the five-year window, Shares Outstanding (Diluted Average) soared 76.66% in 2025 and soared 69.59% in 2026, its largest moves.
• BioCorRx's Shares Outstanding (Diluted Average) stood at $10.5 million in 2024, then soared by 76.66% to $18.5 million in 2025, then soared by 38.48% to $25.6 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $25.6 million (Q1 2026), $18.5 million (Q4 2025), and $16.9 million (Q3 2025), per Business Quant data.